Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public…
Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million Net income of $21.3 million supports non-GAAP net…
February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided statistically significant and clinically meaningful reductions in annualized…
BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed…
Shipments Increase in 2025 Amid Strong AI-driven Demand, While Revenue SoftensMILPITAS, Calif., Feb. 10, 2026 /PRNewswire/ -- Worldwide silicon wafer…
TAINAN, Feb. 10, 2026 /PRNewswire/ -- MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive…
ALPHARETTA, Ga., Feb. 09, 2026 (GLOBE NEWSWIRE) -- As manufacturers and distributors move beyond AI experimentation, Aptean, a global leader…
Company Reaches Settlements in Two Separate Pending Litigation Cases to Resolve Large Portion of Potential Financial Liability February 06, 2026…
February 06, 2026 03:30 ET | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Feb. 06,…
DUBAI, UAE, Feb. 5, 2026 /PRNewswire/ -- Dubai International Financial Centre (DIFC) announced landmark annual results that underscore Dubai's prominence…